Pricing Log in Create free account

Satellos Bioscience Inc. (MSLE) vs NovaBridge Biosciences (NBP)

Satellos Bioscience Inc. and NovaBridge Biosciences are both Biotechnology companies. Satellos Bioscience Inc. and NovaBridge Biosciences are of similar size ($149.6M and $145.1M). Across the 8 metrics below, Satellos Bioscience Inc. leads on 5 and NovaBridge Biosciences on 3.

Valuation

Metric MSLE NBP Biotechnology median
P/E n/m n/m 8.50
P/S n/m 5.31 9.71
P/B 2.25 0.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.94 0.64
EV/Sales n/m (3.81) 9.21
Earnings yield (29.72%) (38.61%) (33.15%)
Free cash flow yield (21.56%) (89.83%) (25.50%)

Profitability

Metric MSLE NBP Biotechnology median
Gross margin — 31.10% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (70.45%) 0.00% (56.36%)
Return on assets (64.76%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MSLE NBP Biotechnology median
Revenue growth (TTM) — (91.84%) 6.02%
EPS growth (last fiscal year) 21.20% (77.78%) 30.26%
Revenue growth, 5-year CAGR — (40.00%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MSLE NBP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.22 7.64 4.72
Net debt to EBITDA 1.05 2.26 0.96

Dividend

Metric MSLE NBP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MSLE NBP Biotechnology median
Market cap 145.14m 149.64m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack